2022
Breast Medical Oncologists' Perspectives of Telemedicine for Breast Cancer Care: A Survey Study
Stavrou E, Qiu J, Zafar A, Tramontano AC, Isakoff S, Winer E, Schrag D, Manz C. Breast Medical Oncologists' Perspectives of Telemedicine for Breast Cancer Care: A Survey Study. JCO Oncology Practice 2022, 18: e1447-e1453. PMID: 35671420, PMCID: PMC9509057, DOI: 10.1200/op.22.00072.Peer-Reviewed Original ResearchMeSH KeywordsBreast NeoplasmsCOVID-19FemaleHumansOncologistsPandemicsSurveys and QuestionnairesTelemedicineUnited StatesConceptsBreast cancer careCancer carePercent of respondentsCancer CenterDana-Farber Cancer InstituteBreast cancer followMedical oncologist's perspectiveAcademic cancer centerPatient-physician communicationUse of telemedicineMost respondentsTM visitsCancer followRoutine followOncologist's perspectiveOncology visitsPatient adherenceOncology cliniciansClinicians' perceptionsFace visitsBreast cliniciansCancer InstituteSecond opinion consultationPatient carePatient recordsPerceptions of patients and medical oncologists toward biospecimen donation in the setting of abnormal breast imaging findings
Seah DS, Tayob N, Leone JP, Hu J, Yin J, Hughes M, Scott SM, Lederman RI, Frank E, Sohl JJ, Stadler ZK, Erick TK, Peppercorn J, Winer EP, Silverman SG, Come SE, Lin NU. Perceptions of patients and medical oncologists toward biospecimen donation in the setting of abnormal breast imaging findings. Breast Cancer Research And Treatment 2022, 192: 201-210. PMID: 35066788, DOI: 10.1007/s10549-021-06494-z.Peer-Reviewed Original ResearchConceptsAdditional biospecimensMedical oncologistsBreast biopsyBreast tissueBiopsy resultsSingle academic medical centerBreast medical oncologistsPain/discomfortPerceptions of patientsMost medical oncologistsAbnormal breastDiagnostic breast biopsyAcademic medical centerPercutaneous breast biopsyNational Cancer InstituteDonation of bloodCancer CenterDiagnostic biopsyPercutaneous biopsyMedical CenterBiopsyCancer InstitutePatientsOncologistsProcedure risk
2020
Barriers to Clinical Trial Accrual: Perspectives of Community-Based Providers
Knelson LP, Cukras AR, Savoie J, Agarwal A, Guo H, Hu J, Fell G, Lederman R, Hughes ME, Winer EP, Lin NU, Tolaney SM. Barriers to Clinical Trial Accrual: Perspectives of Community-Based Providers. Clinical Breast Cancer 2020, 20: 395-401.e3. PMID: 32605813, DOI: 10.1016/j.clbc.2020.05.001.Peer-Reviewed Original ResearchConceptsTrial participationTrial referralClinical trialsBreast cancerNurse practitioners/physician assistantsPatient-related barriersReferral of patientsClinical Trial AccrualCancer enrollMetastatic trialsReferral patternsSurgical oncologistsTrial awarenessReferral practicesTrial investigatorsBreast oncologyTrial knowledgePatientsPhysician assistantsTrial optionsMedical education coursesPatient interestReferralProvider perspectivesLogistical barriers
2017
Adjuvant Chemotherapy for ER+ Breast Cancer: A Sea Change is Underway
Poorvu PD, Winer EP. Adjuvant Chemotherapy for ER+ Breast Cancer: A Sea Change is Underway. Journal Of The National Cancer Institute 2017, 110: 443-445. PMID: 29237035, DOI: 10.1093/jnci/djx264.Peer-Reviewed Original Research